Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
May
7
2024
Navigating the Regulatory Maze: Hemp Industry Calls for Additional Federal Action Squire Patton Boggs (US) LLP
May
7
2024
Cannabis Operator Challenges California State Statute and Regulations Requiring Labor Peace Agreements Sheppard, Mullin, Richter & Hampton LLP
May
7
2024
Food & Chemicals Unpacked: Much Ado About TiO2 [Podcast] Keller and Heckman LLP
May
7
2024
Florida Bans “Cultivated” Meat- First in a Potential Series of Similar Bans Beveridge & Diamond PC
May
7
2024
Now That It Appears Marijuana Is Being Rescheduled, How Does That Process Work? Bradley Arant Boult Cummings LLP
May
7
2024
Courts Neutralize Baseless Acid Lawsuits Proskauer Rose LLP
May
7
2024
Singapore Introduces New Legislation Regulating Food Alternative Proteins and More Keller and Heckman LLP
May
7
2024
FDA Finalizes Ag Water Rule Keller and Heckman LLP
May
7
2024
Live from Workplace Horizons 2024 - Episode 1: What Employers Need to Know About Keeping Your Workplace Safe, Drug-Free, and Productive [Podcast] Jackson Lewis P.C.
May
6
2024
Old North State Report – May 6, 2024 Nelson Mullins
May
6
2024
Federal Update on Cannabis Scheduling: Are State Legalized Cannabis Dispensaries to Become Pharmacies? Epstein Becker & Green, P.C.
May
6
2024
Healthcare Preview for the Week of: May 6, 2024 [Podcast] McDermott Will & Emery
May
6
2024
FDA’s Final LDT Rule Is Here, and the Changes Show the Agency Is Serious and Actually Listening to Stakeholders Mintz
May
6
2024
A New Day for “Natural” Claims? Keller and Heckman LLP
May
6
2024
FDA Finalizes Rule Regulating Laboratory Developed Tests Polsinelli PC
May
3
2024
Congress Extends Statute of Limitations for Sanctions Violations Hunton Andrews Kurth
May
3
2024
Second Circuit Upholds Summary Judgment for Defendants Against Allegations That "All Natural" Label Was Misleading Mintz
May
3
2024
McdermottPlus Check-Up: May 3, 2024 McDermott Will & Emery
May
2
2024
And They’re (Almost) Off! Kentucky’s Medical Cannabis Applications Due Soon Bradley Arant Boult Cummings LLP
May
2
2024
CIPL Publishes Report on Enabling Beneficial and Safe Uses of Biometric Technology Through Risk-Based Regulations Hunton Andrews Kurth
May
2
2024
DEA Accepts HHS Recommendation to Reschedule Cannabis [Podcast] Womble Bond Dickinson (US) LLP
May
1
2024
ChemCatBio Seeks Community Feedback on Local Manufacturing Bergeson & Campbell, P.C.
May
1
2024
DOJ Plans to Reclassify Marijuana From Schedule I to Lower-Risk Schedule III Drug Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
1
2024
Spring Has Sprung Obviousness Trends from the Federal Circuit Bradley Arant Boult Cummings LLP
May
1
2024
Lawsuit Targets 100% Juice Claim Keller and Heckman LLP
May
1
2024
FDA Issues Final Rule Regulating Many Laboratory-Developed Tests as Medical Devices McDermott Will & Emery
Apr
30
2024
FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests Sheppard, Mullin, Richter & Hampton LLP
Apr
30
2024
DEA Poised to Reschedule Marijuana Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins